SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Oscient Pharmaceuticals Corp. (OSCI)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jeff Lee who wrote (90)10/24/1996 5:53:00 PM
From: Tara Cobble   of 1154
 
Jeff, Robert had a post #91 that mentions what the street had expected and Peter also had post #92 with other good comments.

Spoke with my broker today and his information was the following:
Smith & Barney had expected a 4th qtr loss of 7 cents (reality was 5 cents). For the year end the expectation was a loss of 8 cents (reality was profit of 11 cents).

The first quarter expectation is for a loss of 15 cents which my broker does not believe to be realistic with Gene's current track record (meaning he expects better results than a 15 cent loss).

I think GENE is planning a visit with brokerage house (s) next week or something like that. Has anybody else heard this or that they will be meeting with analysts to review progress and update the street on what the future holds???? I would think this would be positive news and agree with Peter that GENE is looking to be in good shape. I think that agreements will move this stock more than earnings. When they sign some more agreements (when?????) then this should move the stock back up over the resistance level -- believe to be around $10. If it does move above that I don't know how much it can move before settling down again ---- any guesses from you guys.

Tara
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext